GIP
BMY icon

Granite Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Granite Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,732
Closed -$311K – 257
2024
Q1 		$311K Sell
5,732
-12,309
-68% -$627K 0.01% 235
2023
Q4 		$926K Sell
18,041
-3,200
-15% -$168K 0.04% 215
2023
Q3 		$1.23M Sell
21,241
-200
-0.9% -$12.3K 0.05% 208
2023
Q2 		$1.37M Sell
21,441
-350
-2% -$23.5K 0.05% 202
2023
Q1 		$1.51M Sell
21,791
-395
-2% -$27.9K 0.06% 199
2022
Q4 		$1.6M Hold
22,186
– – 0.07% 209
2022
Q3 		$1.58M Hold
22,186
– – 0.07% 200
2022
Q2 		$1.71M Hold
22,186
– – 0.07% 203
2022
Q1 		$1.62M Sell
22,186
-1,000
-4% -$67.1K 0.06% 210
2021
Q4 		$1.45M Sell
23,186
-5,528
-19% -$324K 0.04% 219
2021
Q3 		$1.7M Hold
28,714
– – 0.05% 209
2021
Q2 		$1.92M Sell
28,714
-200
-0.7% -$13K 0.06% 211
2021
Q1 		$1.82M Buy
28,914
+1,200
+4% +$74.7K 0.06% 204
2020
Q4 		$1.72M Sell
27,714
-3,200
-10% -$197K 0.06% 204
2020
Q3 		$1.86M Sell
30,914
-800
-3% -$48.1K 0.08% 192
2020
Q2 		$1.86M Hold
31,714
– – 0.09% 185
2020
Q1 		$1.77M Sell
31,714
-592
-2% -$36.2K 0.11% 174
2019
Q4 		$2.07M Buy
32,306
+3,908
+14% +$224K 0.1% 191
2019
Q3 		$1.44M Sell
28,398
-3,000
-10% -$141K 0.07% 202
2019
Q2 		$1.42M Sell
31,398
-915
-3% -$42.6K 0.08% 190
2019
Q1 		$1.54M Sell
32,313
-1,191
-4% -$59.3K 0.09% 164
2018
Q4 		$1.74M Sell
33,504
-76,238
-69% -$4.1M 0.13% 131
2018
Q3 		$6.81M Sell
109,742
-4,977
-4% -$295K 0.39% 94
2018
Q2 		$6.35M Sell
114,719
-10,966
-9% -$592K 0.4% 96
2018
Q1 		$7.95M Buy
125,685
+378
+0.3% +$24.3K 0.53% 85
2017
Q4 		$7.68M Sell
125,307
-4,706
-4% -$294K 0.48% 87
2017
Q3 		$8.29M Sell
130,013
-6,554
-5% -$383K 0.52% 82
2017
Q2 		$7.61M Sell
136,567
-11,950
-8% -$650K 0.51% 82
2017
Q1 		$8.08M Sell
148,517
-4,033
-3% -$221K 0.55% 82
2016
Q4 		$8.91M Sell
152,550
-26,733
-15% -$1.46M 0.66% 64
2016
Q3 		$9.67M Sell
179,283
-5,435
-3% -$349K 0.72% 44
2016
Q2 		$13.6M Buy
184,718
+2,491
+1% +$176K 1.07% 13
2016
Q1 		$11.6M Buy
182,227
+32,440
+22% +$2.05M 1.05% 11
2015
Q4 		$10.3M Buy
149,787
+29,234
+24% +$1.93M 0.93% 18
2015
Q3 		$7.14M Sell
120,553
-494
-0.4% -$31.3K 0.69% 44
2015
Q2 		$8.05M Sell
121,047
-1,949
-2% -$128K 0.74% 35
2015
Q1 		$7.93M Buy
122,996
+462
+0.4% +$28.9K 0.68% 51
2014
Q4 		$7.23M Sell
122,534
-10,019
-8% -$565K 0.81% 28
2014
Q3 		$6.78M Sell
132,553
-6,693
-5% -$334K 0.93% 31
2014
Q2 		$6.75M Buy
139,246
+104,544
+301% +$5.15M 0.96% 33
2014
Q1 		$1.8M Hold
34,702
– – 0.28% 97
2013
Q4 		$1.84M Buy
34,702
+200
+0.6% +$10.2K 0.28% 96
2013
Q3 		$1.6M Buy
34,502
+300
+0.9% +$13.2K 0.26% 107
2013
Q2 		$1.53M Buy
+34,202
New +$1.48M 0.27% 103

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Granite Investment Partners's BMY Position: Q2 2024 in Review

Granite Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 5,732 shares — an estimated $311K sold.

Granite Investment Partners first reported a position in BMY in Q2 2013 and held it in 44 quarters. The position peaked at $13.6M in Q2 2016. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Granite Investment Partners reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Granite Investment Partners sold 5,732 Bristol-Myers Squibb shares in Q2 2024, an estimated $311K.
  • Granite Investment Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 44 quarters.
  • Granite Investment Partners's Bristol-Myers Squibb position peaked at $13.6M in Q2 2016.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Granite Investment Partners's 13F filing for Q2 2024, filed 12 Aug 2024.